AARD compared with BYSI: revenue, margins and what each company keeps, and the suppliers and customers both name

AARDAardvark Therapeutics, Inc.

Mkt capRevenueRevenue

BYSIBeyondSpring Inc.

Mkt capRevenueRevenue

Compare

AARDAardvark Therapeutics, Inc.

BYSIBeyondSpring Inc.

Price

Mkt cap

Revenue

Earnings history

Not investment advice. Not a broker-dealer. Indices shown as ETF proxies. Supply-chain data CC BY 4.0; market data not redistributable.

Listed on One’s Vibe · live-checked · Oct ’26

last 4 reports each · paired by recencyMethod ›

AARD

0 of 3at or beyond implied

Reportimpliedrealized× implied

Q2 FY26±54.2%▼−8.62%×0.16

May 7 '26±56.7%▼−4.92%×0.09

Q1 FY26±89.9%▼−7.26%×0.08

Q3 FY25—▼−8.66%—

BYSI1 of 4 reports

Reportimpliedrealized× implied

Q2 FY26—▼−15.21%—

= impliedAARD realized, solidBYSI realized, hatchedOne scale, both sides: full bar = 90%× = |realized| ÷ impliedSource: market data

AARDAardvark Therapeutics, Inc.

1.24▼−8.52%· post 1.32

Mkt cap$29.7M

BYSIBeyondSpring Inc.

0.79▲+23.44%· post 0.84

ClosedNov 2 '26

Mkt cap$33.1M

Compare

ClosedNov 2 '26

AARDAardvark Therapeutics, Inc.

BYSIBeyondSpring Inc.

1.24▼−8.52%post 1.32

Price

0.79▲+23.44%post 0.84

$29.7M

Mkt cap

$33.1M

AARD1.24▼−8.52%vsBYSI0.79▲+23.44%ClosedNov 2 '26